These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1627017)

  • 1. A critical appraisal of ticlopidine, a new antiplatelet agent. Effectiveness and clinical indications for prophylaxis of atherosclerotic events.
    Haynes RB; Sandler RS; Larson EB; Pater JL; Yatsu FM
    Arch Intern Med; 1992 Jul; 152(7):1376-80. PubMed ID: 1627017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.
    BMJ; 1994 Jan; 308(6921):81-106. PubMed ID: 8298418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet therapy in the prevention of ischaemic stroke.
    Verry M; Panak E; Cazenave JP
    Nouv Rev Fr Hematol (1978); 1994 Jun; 36(3):213-28. PubMed ID: 7971242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ticlopidine: a new platelet aggregation inhibitor.
    Ito MK; Smith AR; Lee ML
    Clin Pharm; 1992 Jul; 11(7):603-17. PubMed ID: 1617911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ticlopidine: a new antiplatelet agent for the secondary prevention of stroke.
    Murray JC; Kelly MA; Gorelick PB
    Clin Neuropharmacol; 1994 Feb; 17(1):23-31. PubMed ID: 8149356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease.
    Mehta SR; Yusuf S;
    Eur Heart J; 2000 Dec; 21(24):2033-41. PubMed ID: 11102254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ticlopidine hydrochloride use and threatened stroke.
    Rothrock JF; Hart RG
    West J Med; 1994 Jan; 160(1):43-7. PubMed ID: 8128701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group.
    Hass WK; Easton JD; Adams HP; Pryse-Phillips W; Molony BA; Anderson S; Kamm B
    N Engl J Med; 1989 Aug; 321(8):501-7. PubMed ID: 2761587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
    Fox KA; Mehta SR; Peters R; Zhao F; Lakkis N; Gersh BJ; Yusuf S;
    Circulation; 2004 Sep; 110(10):1202-8. PubMed ID: 15313956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ticlopidine: a new antiplatelet agent for cerebrovascular disease.
    Robert S; Miller AJ; Fagan SC
    Pharmacotherapy; 1991; 11(4):317-22; discussion 322-5. PubMed ID: 1923914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
    Reaume KT; Regal RE; Dorsch MP
    Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?
    Hermosillo AJ; Spinler SA
    Ann Pharmacother; 2008 Jun; 42(6):790-805. PubMed ID: 18477734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in long-term stroke prevention with antiplatelet therapy.
    Brass LM
    J Stroke Cerebrovasc Dis; 2001; 10(2 Pt 2):18-23. PubMed ID: 17903845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
    Bhatt DL; Topol EJ;
    Am Heart J; 2004 Aug; 148(2):263-8. PubMed ID: 15308995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clopidogrel: secondary prevention of vascular ischaemic events.
    Misson J; Clark W; Kendall MJ
    J Clin Pharm Ther; 1998 Apr; 23(2):91-5. PubMed ID: 9786094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of antiplatelet medication for prevention of myocardial infarction and stroke.
    Rakel RE
    Heart Dis Stroke; 1992; 1(1):2-3. PubMed ID: 1344081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual antiplatelet agent failure: a new syndrome or clinical nonentity?
    Barnes GD; Li J; Kline-Rogers E; Vedre A; Armstrong DF; Froehlich JB; Eagle KA; Gurm HS
    Am Heart J; 2007 Oct; 154(4):732-5. PubMed ID: 17893001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
    Kirshner HS
    Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
    Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.